Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

16

Revenue 2017

Shire

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Shire's 2013 CNS, immunology and metabolic's sales performance.

Shire

Shire’s bleeding disorder drug approved in Europe

Shire’s bleeding disorder drug approved in Europe Veyvondi for patients with rare disease von Willebrand disease. The European Commission (EC) has given the green light to Shire’s haemostatic disorder treatment Veyvondi, which is now set to prevent ... Andreas Busch, head of research and development

Takeda rebels take aim at Shire acquisition

Takeda rebels take aim at Shire acquisition Shareholder group concerned about $30bn debt burden. Opposition to Takeda’s yet-to-be-finalised $63bn takeover of Shire appears to be building among some shareholders in Japan. ... A small but increasingly vocal group of rebel investors – including

Sangamo’s first gene-editing trial doesn’t convince investors

Sangamo’s first gene-editing trial doesn’t convince investors came, even though patients in the study are being treated with Shire’s Elaprase (idursulfase), a recombinant form of IDS used as enzyme replacement therapy (ERT) that has transformed the outlook

Pfizer abandons antibody for Duchenne

Pfizer abandons antibody for Duchenne Novartis and Morphosys gave up on their bimagrumab for muscle-wasting disease sporadic inclusion body myositis two years ago, while Shire/Acceleron and Amgen have also chalked up failures in this

Roche highlights Hemlibra data as key FDA date approaches

Roche highlights Hemlibra data as key FDA date approaches every few days, such as Shire’s Adynovate, Biogen’s Eloctate, Bayer’s Kovaltry and CSL Behring’s Afstyla, uptake hasn’t been as quick as hoped. ... centred on a type of blood clot called thrombotic microangiopathy and a legal challenge from

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics